报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 13.27% | 4.49% | 75.07% | 8/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 7.58% | 5.87% | 77.93% | 13/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 4.26% | 4.41% | -73% | 13/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 15.78% | -7.77% | 24.25% | 8/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 12.7% | -26.29% | 77.37% | 10/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 7.16% | -40.63% | 75.49% | 22/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 4.08% | -30.49% | -76.15% | 22/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 17.11% | -2.06% | -0.7% | 36/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 17.23% | 22.37% | 42.87% | 27/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 12.06% | 45.3% | 105.45% | 28/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 5.87% | 38.44% | -66.4% | 23/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 17.47% | 24.08% | 24.08% | 45/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 14.08% | 7.81% | 69.64% | 42/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 8.3% | 17.9% | 95.75% | 49/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 4.24% | 114.14% | -69.89% | 38/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 14.08% | 64.87% | 7.81% | 70/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 13.06% | 102.48% | 85.51% | 44/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 7.04% | 171.81% | 255.56% | 57/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | 1.98% | 138.55% | -76.81% | 40/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | 8.54% | 38.64% | 32.4% | 85/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
2019-09-30 | 6.45% | 30.04% | 149.03% | 44/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
2019-06-30 | 2.59% | 4.86% | 212.05% | 57/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
2019-03-31 | 0.83% | -27.19% | -86.53% | 46/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
2018-12-31 | 6.16% | -7.51% | 24.19% | 84/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
2018-09-30 | 4.96% | -12.83% | 100.81% | 36/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
2018-06-30 | 2.47% | -21.34% | 116.67% | 44/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
2018-03-31 | 1.14% | -3.39% | -82.88% | 39/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
2017-12-31 | 6.66% | -3.62% | 17.05% | 74/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
2017-09-30 | 5.69% | -1.39% | 81.21% | 33/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
2017-06-30 | 3.14% | -2.18% | 166.1% | 43/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
2017-03-31 | 1.18% | -31.79% | -82.92% | 36/129 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
2016-12-31 | 6.91% | -36.55% | 19.76% | 61/129 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
2016-09-30 | 5.77% | -36.52% | 79.75% | 25/129 | 8.69% | 安图生物 | 28% | 行业排名> |
2016-06-30 | 3.21% | -56.74% | 85.55% | 35/129 | 6.26% | 明德生物 | 23.29% | 行业排名> |
2016-03-31 | 1.73% | 2% | -84.11% | 19/129 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
2015-12-31 | 10.89% | -44.44% | 19.8% | 39/129 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
2015-09-30 | 9.09% | 2% | 22.51% | 13/129 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
2015-06-30 | 7.42% | 2% | -62.14% | 18/129 | 7.77% | 明德生物 | 29.93% | 行业排名> |